Sherry Korczynski, Chief Commercial Officer at Aquestive Therapeutics ($AQST), made one open market sale of company shares in the last year, totaling about $66,000. Her most recent sale occurred on March 10, 2026. Among 11,678 insiders with sales over the past year, her activity ranks 10,084th by value, well below the average of $8.6 million across roughly 6.4 transactions per insider. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Aquestive Therapeutics, Inc. | $AQST | Korczynski Sherry | Chief Commercial Officer | A | Common Stock | 75000 | $0.00 | 256,858.0000 | 122,003,113 | 41.24% | 0.06% |
| March 9, 2026 | Aquestive Therapeutics, Inc. | $AQST | Korczynski Sherry | Chief Commercial Officer | A | Non-Qualified Stock Option (right to buy) | 42500 | $4.29 | 42,500.0000 | 122,003,113 | 9999.99% | 0.03% |
| March 10, 2026 | Aquestive Therapeutics, Inc. | $AQST | Korczynski Sherry | Chief Commercial Officer | S | Common Stock | 15741 | $4.17 | 241,117.0000 | 122,003,113 | 6.13% | 0.01% |
| Aug. 14, 2025 | Aquestive Therapeutics, Inc. | $AQST | Korczynski Sherry | Chief Commercial Officer | A | Common Stock | 25000 | $0.00 | 181,858.0000 | 98,871,369 | 15.94% | 0.03% |
| June 9, 2025 | Aquestive Therapeutics, Inc. | $AQST | Korczynski Sherry | SVP Sales and Marketing | F | Common Stock | 2714 | $3.54 | 156,858.0000 | 98,871,369 | 1.70% | 0.00% |
| March 7, 2025 | Aquestive Therapeutics, Inc. | $AQST | Korczynski Sherry | SVP Sales and Marketing | A | Non-Qualified Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 98,871,369 | 9999.99% | 0.04% |
| March 7, 2025 | Aquestive Therapeutics, Inc. | $AQST | Korczynski Sherry | SVP Sales and Marketing | F | Common Stock | 5428 | $2.65 | 159,572.0000 | 98,871,369 | 3.29% | 0.01% |
| March 7, 2025 | Aquestive Therapeutics, Inc. | $AQST | Korczynski Sherry | SVP Sales and Marketing | A | Common Stock | 90000 | $0.00 | 165,000.0000 | 98,871,369 | 120.00% | 0.09% |
| June 7, 2024 | Aquestive Therapeutics, Inc. | $AQST | Korczynski Sherry | SVP Sales and Marketing | A | Common Stock | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |